Cyclin B1 proteolysis via p38 MAPK signaling participates in G2 checkpoint elicited by arsenite

Journal of Cellular Physiology

Volumn 212, Issue 2, 2007, Pages 481-488

  Li, Ju Pi ^a   Yang, Jia Ling ^a  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC TRIOXIDE; CELL CYCLE PROTEIN 20; CYCLIN B1; CYCLIN DEPENDENT KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 6; MITOGEN ACTIVATED PROTEIN KINASE P38; UVOMORULIN;

ARTICLE; CELL CYCLE G2 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CONTROLLED STUDY; DNA DAMAGE; ENZYME ACTIVATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

APOPTOSIS; ARSENITES; CARCINOGENS, ENVIRONMENTAL; CDC2 PROTEIN KINASE; CELL DIVISION; CELL LINE, TUMOR; CELL SURVIVAL; CYCLIN B; CYCLOHEXIMIDE; ENZYME ACTIVATION; G2 PHASE; HUMANS; IMIDAZOLES; LEUPEPTINS; MAP KINASE SIGNALING SYSTEM; MICRONUCLEI, CHROMOSOME-DEFECTIVE; MITOGEN-ACTIVATED PROTEIN KINASE 14; MITOSIS; PEPTIDE HYDROLASES; PHOSPHORYLATION; PROTEASE INHIBITORS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN KINASE INHIBITORS; PROTEIN SYNTHESIS INHIBITORS; PYRIDINES; SODIUM COMPOUNDS; UBIQUITIN; UBIQUITIN-PROTEIN LIGASE COMPLEXES;

EID: 34347385439     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21042     Document Type: Article

References (52)

1. 2/M arrest in human cells. Mol Cell Biol 20:2358-2366.
2. Bassermann F, von Klitzing C, Munch S, Bai RY, Kawaguchi H, Morris SW, Peschel C, Duyster J. 2005. NIPA defines an SCF-type mammalian E3 ligase that regulates mitotic entry. Cell 122:45-57.
3. Basu A, Mahata J, Gupta S, Giri AK. 2001. Genetic toxicology of a paradoxical human carcinogen, arsenic: A review. Mutat Res 488:171-194.
4. Bates MN, Smith AH, Hopenhayn-Rich C. 1992. Arsenic ingestion and internal cancers: A review. Am J Epidemiol 135:462-476.
5. Bulavin DV, Higashimoto Y, Popoff IJ, Gaarde WA, Basrur V, Potapova O, Appella E, Fornace AJ, Jr. 2001. Initiation of a G2/M checkpoint after ultraviolet radiation requires p38 kinase. Nature 411:102-107.
6. Busino L, Donzelli M, Chiesa M, Guardavaccaro D, Ganoth D, Dorrello NV, Hershko A, Pagano M, Draetta GF. 2003. Degradation of Cdc25A by β-TrCP during S phase and in response to DNA damage. Nature 426:87-91.
7. Cavigelli M, Li WW, Lin A, Su B, Yoshioka K, Karin M. 1996. The tumor promoter arsenite stimulates AP-1 activity by inhibiting a JNK phosphatase. EMBO J 15:6269-6279.
8. Chao JI, Yang JL. 2001. Opposite roles of ERK and p38 mitogen-activated protein kinases in cadmium-induced genotoxicity and mitotic arrest. Chem Res Toxicol 14:1193-1202.
9. Chen F, Lu Y, Zhang Z, Vallyathan V, Ding M, Castranova V, Shi X. 2001. Opposite effect of NF-κB and c-Jun N-terminal kinase on p53-independent GADD45 induction by arsenite. J Biol Chem 276:11414-11419.
10. Chen F, Zhang Z, Bower J, Lu Y, Leonard SS, Ding M, Castranova V, Piwnica-Worms H, Shi X. 2002. Arsenite-induced Cdc25C degradation is through the KEN-box and ubiquitin-proteasome pathway. Proc Natl Acad Sci USA 99:1990-1995.
11. Chiou HY, Chiou ST, Hsu YH, Chou YL, Tseng CH, Wei ML, Chen CJ. 2001. Incidence of transitional cell carcinoma and arsenic in drinking water: A follow-up study of 8,102 residents in an arseniasis-endemic area in northeastern Taiwan. Am J Epidemiol 153: 411-418.
12. Cogswell JP, Godlevski MM, Bonham M, Bisi J, Babiss L. 1995. Upstream stimulatory factor regulates expression of the cell cycle-dependent cyclin B1 gene promoter. Mol Cell Biol 15:2782-2790.
13. 2/M checkpoint after hypertonic stress in renal inner medullary epithelial (IME) cells is protective and requires p38 kinase. Proc Natl Acad Sci USA 99:184-189.
14. Donzelli M, Draetta GF. 2003. Regulating mammalian checkpoints through Cdc25 inactivation. EMBO Rep 4:671-677.
15. 2 checkpoint. Oncogene 21:8089-8104.
16. Hagting A, Jackman M, Simpson K, Pines J. 1999. Translocation of cyclin B1 to the nucleus at prophase requires a phosphorylation-dependent nuclear import signal. Curr Biol 9:680-689.
17. 2 checkpoint and to resistance to chemotherapeutic DNA-methylating agents. Mol Cell Biol 23:8306-8315.
18. Huang SC, Lee TC. 1998. Arsenite inhibits mitotic division and perturbs spindle dynamics in HeLa S3 cells. Carcinogenesis 19:889-896.
19. IARC. 1987. Arsenic and arsenic compounds. Overall evaluation of carcinogenicity: An updating of IARC monographs. Lyon: IARC, Lyon, pp 100-106.
20. 2 checkpoint through cyclin B1. Proc Natl Acad Sci USA 96:2147-2152.
21. 2/M delay caused by arsenite. Mol Carcinog 43:1-12.
22. Jin P, Hardy S, Morgan DO. 1998. Nuclear localization of cyclin B1 controls mitotic entry after DNA damage. J Cell Biol 141:875-885.
23. Kim JY, Choi JA, Kim TH, Yoo YD, Kim JI, Lee YJ, Yoo SY, Cho CK, Lee YS, Lee SJ. 2002. Involvement of p38 mitogen-activated protein kinase in the cell growth inhibition by sodium arsenite. J Cell Physiol 190:29-37.
24. King RW, Deshaies RJ, Peters JM, Kirschner MW. 1996. How proteolysis drives the cell cycle. Science 274:1652-1659.
25. Laoukili J, Kooistra MR, Bras A, Kauw J, Kerkhoven RM, Morrison A, Clevers H, Medema RH. 2005. FoxM1 is required for execution of the mitotic programme and chromosome stability. Nat Cell Biol 7:126-136.
26. Li J, Meyer AN, Donoghue DJ. 1997. Nuclear localization of cyclin B1 mediates its biological activity and is regulated by phosphorylation. Proc Natl Acad Sci USA 94:502-507.
27. Li JP, Lin JC, Yang JL. 2006. ERK activation in arsenite-treated G1-enriched CL3 cells contributes to survival, DNA repair inhibition, and micronucleus formation. Toxicol Sci 89:164-172.
28. Li SP, Junttila MR, Han J, Kahari VM, Westermarck J. 2003. p38 Mitogen-activated protein kinase pathway suppresses cell survival by inducing dephosphorylation of mitogen-activated protein/extracellular signal-regulated kinase kinase 1,2. Cancer Res 63:3473-3477.
29. Lin YW, Chuang SM, Yang JL. 2003. ERK1/2 achieves sustained activation by stimulating MAPK phosphatase-1 degradation via the ubiquitin-proteasome pathway. J Biol Chem 278:21534-21541.
30. Liu Y, Guyton KZ, Gorospe M, Xu Q, Lee JC, Holbrook NJ. 1996. Differential activation of ERK, JNK/SAPK and P38/CSBP/RK map kinase family members during the cellular response to arsenite. Free Radic Biol Med 21:771-781.
31. 2/M transition and S phase progression in response to UV irradiation. Mol Cell 17:37-48.
32. 2 arrest. J Biol Chem 276:5570-5576.
33. Matsusaka T, Pines J. 2004. Chfr acts with the p38 stress kinases to block entry to mitosis in mammalian cells. J Cell Biol 166:507-516.
34. 2/M arrest in U937 myeloid leukemia cells. J Pharmacol Exp Ther 313:877-887.
35. 2/M transition by triggering the p38 MAPK checkpoint pathway. J Cell Biol 166:517-526.
36. Morgan DO. 1997. Cyclin-dependent kinases: Engines, clocks, and microprocessors. Annu Rev Cell Dev Biol 13:261-291.
37. Nebreda AR, Porras A. 2000. p38 MAP kinases: Beyond the stress response. Trends Biochem Sci 25:257-260.
38. Peter M, Le Peuch C, Labbe JC, Meyer AN, Donoghue DJ, Doree M. 2002. Initial activation of cyclin-B1-cdc2 kinase requires phosphorylation of cyclin B1. EMBO Rep 3:551-556.
39. Peters JM. 2002. The anaphase-promoting complex; Proteolysis in mitosis and beyond. Mol Cell 9:931-943.
40. Pines J. 1999. Four-dimensional control of the cell cycle. Nat Cell Biol 1:E73-E79.
41. Porras A, Zuluaga S, Black E, Valladares A, Alvarez AM, Ambrosino C, Benito M, Nebreda AR. 2004. p38α mitogen-activated protein kinase sensitizes cells to apoptosis induced by different stimuli. Mol Biol Cell 15:922-933.
42. Summers MK, Bothos J, Halazonetis TD. 2005. The CHFR mitotic checkpoint protein delays cell cycle progression by excluding Cyclin B1 from the nucleus. Oncogene 24:2589-2598.
43. 2 checkpoint. EMBO J 17:2728-2735.
44. Walsh S, Margolis SS, Kornbluth S. 2003. Phosphorylation of the cyclin B1 cytoplasmic retention sequence by mitogen-activated protein kinase and Plx. Mol Cancer Res 1:280-289.
45. Wang X, McGowan CH, Zhao M, He L, Downey JS, Fearns C, Wang Y, Huang S, Han J. 2000. Involvement of the MKK6-p387 cascade in γ-radiation-induced cell cycle arrest. Mol Cell Biol 20:4543-4552.
46. Yih LH, Ho IC, Lee TC. 1997. Sodium arsenite disturbs mitosis and induces chromosome loss in human fibroblasts. Cancer Res 57:5051-5059.
47. Yih LH, Lee TC. 2000. Arsenite induces p53 accumulation through an ATM-dependent pathway in human fibroblasts. Cancer Res 60:6346-6352.
48. Yuan J, Eckerdt F, Bereiter-Hahn J, Kurunci-Csacsko E, Kaufmann M, Strebhardt K. 2002. Cooperative phosphorylation including the activity of polo-like kinase I regulates the subcellular localization of cyclin B1. Oncogene 21:8282-8292.
49. Zarubin T, Han J. 2005. Activation and signaling of the p38 MAP kinase pathway. Cell Res 15:11-18.
50. Zhou BB, Elledge SJ. 2000. The DNA damage response: Putting checkpoints in perspective. Nature 408:433-439.
51. Zhu J, Chen Z, Lallemand-Breitenbach V, de The H. 2002. How acute promyelocytic leukaemia revived arsenic. Nat Rev Cancer 2:705-713.
52. Zhu W, Giangrande PH, Nevins JR. 2004. E2Fs link the control of G1/S and G2/M transcription. EMBO J 23:4615-4626.